{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:47:14Z","timestamp":1790066834496,"version":"4.0.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T00:00:00Z","timestamp":1365552000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060334","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T20:45:29Z","timestamp":1365626729000},"page":"e60334","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Screening Compounds with a Novel High-Throughput ABCB1-Mediated Efflux Assay Identifies Drugs with Known Therapeutic Targets at Risk for Multidrug Resistance Interference"],"prefix":"10.1371","volume":"8","author":[{"given":"Megan R.","family":"Ansbro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneet","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh V.","family":"Ambudkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart H.","family":"Yuspa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2174\/138920111795163931","article-title":"Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer","volume":"12","author":"JP Gillet","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.drudis.2007.07.021","article-title":"Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects","volume":"12","author":"A Aszalos","year":"2007","journal-title":"Drug Discov Today"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"P Borst","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"G Szakacs","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/138920010794328922","article-title":"Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein","volume":"11","author":"T Tachibana","year":"2010","journal-title":"Curr Drug Metab"},{"key":"ref6","first-page":"4334","article-title":"In situ hybridization analysis of acquisition and loss of the human multidrug-resistance gene","volume":"48","author":"DW Shen","year":"1988","journal-title":"Cancer Res"},{"key":"ref7","first-page":"2793","article-title":"Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines","volume":"48","author":"ML Slovak","year":"1988","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/dmd.111.042721","article-title":"Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells","volume":"40","author":"S Shukla","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"ref9","first-page":"1882","article-title":"Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone","volume":"48","author":"WS Dalton","year":"1988","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-4827(91)90267-X","article-title":"Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells","volume":"196","author":"JL Weaver","year":"1991","journal-title":"Exp Cell Res"},{"key":"ref11","first-page":"4665","article-title":"Characterization of multidrug resistance by fluorescent dyes","volume":"51","author":"D Kessel","year":"1991","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/156720107782151241","article-title":"ABC drug transporters as molecular targets for the prevention of multidrug resistance and drug-drug interactions","volume":"4","author":"AM Calcagno","year":"2007","journal-title":"Curr Drug Deliv"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1016\/S0021-9258(18)42909-2","article-title":"Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase","volume":"267","author":"B Sarkadi","year":"1992","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02110329","article-title":"Drug-stimulated ATPase activity of the human P-glycoprotein","volume":"27","author":"GA Scarborough","year":"1995","journal-title":"J Bioenerg Biomembr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1073\/pnas.89.18.8472","article-title":"Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis","volume":"89","author":"SV Ambudkar","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"MM Gottesman","year":"2002","journal-title":"Annu Rev Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"SV Ambudkar","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/bjc.1996.151","article-title":"A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells","volume":"73","author":"L Homolya","year":"1996","journal-title":"Br J Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00001813-199607000-00012","article-title":"Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay","volume":"7","author":"F Tiberghien","year":"1996","journal-title":"Anticancer Drugs"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1006\/bbrc.2001.6000","article-title":"Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors","volume":"289","author":"EJ Wang","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/adt.2007.107","article-title":"High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters","volume":"6","author":"I Ivnitski-Steele","year":"2008","journal-title":"Assay Drug Dev Technol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/1087057105284576","article-title":"A high-throughput cell-based assay for inhibitors of ABCG2 activity","volume":"11","author":"CJ Henrich","year":"2006","journal-title":"J Biomol Screen"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejpb.2007.10.003","article-title":"Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system","volume":"69","author":"F Forster","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1023\/A:1025040712857","article-title":"Compound profiling for P-glycoprotein at the blood-brain barrier using a microplate screening system","volume":"20","author":"B Bauer","year":"2003","journal-title":"Pharm Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/adt.2008.139","article-title":"A comparative analysis of standard microtiter plate reading versus imaging in cellular assays","volume":"6","author":"PJ Bushway","year":"2008","journal-title":"Assay Drug Dev Technol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF01534700","article-title":"Isolation and genetic characterization of human KB cell lines resistant to multiple drugs","volume":"11","author":"S Akiyama","year":"1985","journal-title":"Somat Cell Mol Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1016\/S0021-9258(19)57466-X","article-title":"Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins","volume":"261","author":"DW Shen","year":"1986","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1124\/dmd.109.031161","article-title":"N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrier","volume":"38","author":"P Kannan","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1158\/1535-7163.MCT-07-0148","article-title":"Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein","volume":"6","author":"K Katayama","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cyto.10066","article-title":"Flow cytometric cytotoxicity assay for measuring mammalian and avian NK cell activity","volume":"47","author":"C Vizler","year":"2002","journal-title":"Cytometry"},{"key":"ref31","first-page":"1535","article-title":"Mitochondrial localization of P-glycoprotein in the human breast cancer cell line MCF-7\/ADM and its functional characterization","volume":"27","author":"Y Shen","year":"2012","journal-title":"Oncol Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1158\/0008-5472.CAN-09-4303","article-title":"The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature","volume":"70","author":"L Li","year":"2010","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"JH Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/B:BIRE.0000007693.33521.18","article-title":"Mitotracker green is a P-glycoprotein substrate","volume":"23","author":"LF Marques-Santos","year":"2003","journal-title":"Biosci Rep"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0960-894X(99)00030-X","article-title":"Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives","volume":"9","author":"M Roe","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0021-9258(18)61633-3","article-title":"Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein","volume":"262","author":"MM Cornwell","year":"1987","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"16796","DOI":"10.1016\/S0021-9258(18)55371-0","article-title":"Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells","volume":"266","author":"I Tamai","year":"1991","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0006-291X(88)80073-1","article-title":"Reduced cyclosporin accumulation in multidrug-resistant cells","volume":"152","author":"H Goldberg","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1742-4658.2009.07484.x","article-title":"Multidrug efflux pumps: drug binding \u2013 gates or cavity","volume":"277","author":"E Crowley","year":"2010","journal-title":"FEBS J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1021\/bi201479k","article-title":"Evidence for modulatory sites at the lipid-protein interface of the human multidrug transporter P-glycoprotein","volume":"51","author":"D Mandal","year":"2012","journal-title":"Biochemistry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/mol.58.3.624","article-title":"Communication between multiple drug binding sites on P-glycoprotein","volume":"58","author":"C Martin","year":"2000","journal-title":"Mol Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"18132","DOI":"10.1074\/jbc.M210413200","article-title":"Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation","volume":"278","author":"N Maki","year":"2003","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11010-012-1232-z","article-title":"The molecular interaction of a copper chelate with human P-glycoprotein","volume":"364","author":"RD Ghosh","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"SM Maira","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/1078-0432.CCR-09-1380","article-title":"Targeting Polo-like kinase in cancer therapy","volume":"16","author":"Y Degenhardt","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1596\/neo.111366","article-title":"Reduced Efficacy of the Plk1 Inhibitor BI 2536 on the Progression of Hepatocellular Carcinoma due to Low Intratumoral Drug Levels","volume":"14","author":"J Haupenthal","year":"2012","journal-title":"Neoplasia"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3109\/00498254.2011.587033","article-title":"Calcein assay: a high-throughput method to assess P-gp inhibition","volume":"41","author":"H Glavinas","year":"2011","journal-title":"Xenobiotica"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1194\/jlr.D018051","article-title":"A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol","volume":"52","author":"S Sankaranarayanan","year":"2011","journal-title":"J Lipid Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1158\/1535-7163.MCT-07-0352","article-title":"New inhibitors of ABCG2 identified by high-throughput screening","volume":"6","author":"CJ Henrich","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1021\/mp050088t","article-title":"A 96-well efflux assay to identify ABCG2 substrates using a stably transfected MDCK II cell line","volume":"3","author":"Y Xiao","year":"2006","journal-title":"Mol Pharm"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T14:33:55Z","timestamp":1644762835000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060334"}},"subtitle":[],"editor":[{"given":"Robert W.","family":"Sobol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,10]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060334","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,10]]}}}